Saturday, October 1, 2022

561.316.3330

Biotechnology News Magazine

PetVivo Changes Brand Name of Signature Osteoarthritis Product to “SPRYNG”

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that the Company has changed the brand name of its therapeutic osteoarthritis and lameness product to “SPRYNG”.

“We are incredibly excited to introduce to the world the new brand name for our therapeutic product that squarely addresses the debilitating impact of osteoarthritis and lameness in companion animals.” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The brand name “SPRYNG” clearly illustrates how PetVivo’s product enhances the mobility and overall quality of life in dogs, horses and other animals.”

Spryng with OsteoCushion Technology is a veterinary medical device comprised of millions of micronized hydrogel matrices, which are derived from the natural components collagen and elastin. OsteoCushion Technology provides both reinforcing natural joint support to replace missing and damaged cartilage as well as delivers natural scaffolding to help the healing of tissue defects. These attributes offer a great solution to the affliction of osteoarthritis for companion animals in a simple in-clinic treatment.

“We believe the brand name “SPRYNG” clearly depicts the beneficial results derived from our therapeutic product administered to animals suffering from osteoarthritis or other lameness afflictions,” said Russ Siakel, Director of Marketing for PetVivo Holdings, Inc. “We have truly witnessed the restoration of a “SPRYNG in the step” of companion animals that have received this life-changing product.”

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine